Diagnoplex Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
Diagnoplex General Information
Description
Developer of non invasive colorectal cancer screening tests. The company develops clinical laboratory kits for screening colorectal cancer, as well as for the detection of colon cancer. It also discovers and optimizes biomarker combinations to detect cancer.
Contact Information
Corporate Office
- Chemin de la Vulliette 4
- CH-1000 Lausanne
- Switzerland
Corporate Office
- Chemin de la Vulliette 4
- CH-1000 Lausanne
- Switzerland
Diagnoplex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 12-Feb-2015 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 07-Jun-2013 | Completed | Startup | |||
| 1. Early Stage VC (Series A) | 10-Dec-2008 | $8.33M | $8.33M | Completed | Startup |
Diagnoplex Patents
Diagnoplex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20150299802-A1 | Biomarker combinations for colorectal tumors | Active | 05-Nov-2012 | ||
| WO-2014068124-A1 | Biomarker combinations for colorectal tumors | Inactive | 05-Nov-2012 | ||
| AU-2008300338-A1 | Biomarker combinations for colorectal cancer | Inactive | 04-Jun-2007 | ||
| CA-2688558-A1 | Biomarker combinations for colorectal cancer | Inactive | 04-Jun-2007 | ||
| EP-2171470-A2 | Biomarker combinations for colorectal cancer | Inactive | 04-Jun-2007 | G01N33/57535 |
Diagnoplex Signals
Diagnoplex Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DEFI Gestion | PE/Buyout | Minority | ||
| Debiopharm Innovation Fund | Corporate Venture Capital | Minority | ||
| NeoMed Management | Venture Capital | Minority | ||
| Novartis Venture Fund | Corporate Venture Capital | Minority |
Diagnoplex FAQs
-
When was Diagnoplex founded?
Diagnoplex was founded in 2004.
-
Where is Diagnoplex headquartered?
Diagnoplex is headquartered in Lausanne, Switzerland.
-
What is the size of Diagnoplex?
Diagnoplex has 7 total employees.
-
What industry is Diagnoplex in?
Diagnoplex’s primary industry is Laboratory Services (Healthcare).
-
Is Diagnoplex a private or public company?
Diagnoplex is a Private company.
-
What is Diagnoplex’s current revenue?
The current revenue for Diagnoplex is .
-
How much funding has Diagnoplex raised over time?
Diagnoplex has raised $9.7M.
-
Who are Diagnoplex’s investors?
DEFI Gestion, Debiopharm Innovation Fund, NeoMed Management, and Novartis Venture Fund have invested in Diagnoplex.
-
When was Diagnoplex acquired?
Diagnoplex was acquired on 12-Feb-2015.
-
Who acquired Diagnoplex?
Diagnoplex was acquired by Novigenix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process